Last reviewed · How we verify

NCT02949609: MT

Mirror Therapy: Effects on Functional Recuperation of Severe Upper Limb Paresis After Stroke

Terminated NA Last updated 30 September 2019
What this trial tests

NA trial testing Mirror Therapy in Stroke in 23 participants. Terminated before completion.

Timeline
17 June 2016
Primary endpoint
17 November 2017
17 November 2017

Quick facts

Lead sponsorUniversity Hospital, Geneva
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment23
Start date17 June 2016
Primary completion17 November 2017
Estimated completion17 November 2017
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Geneva

Who can join

Eligibility, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After stroke, patients frequently suffer from arm or hand weakness. There are numerous rehabilitation methods to stimulate recovery, amongst which mirror therapy (MT). It is particularly interesting in cases for which impairment is severe, as many other forms of therapy are often impossible. During MT, a mirror is placed in the midsagittal plane, so as to hide the impaired limb. Thereafter, the subject is asked to move his unimpaired limb while looking at its reflection in the mirror, thereby creating the illusion that the contralateral, impaired limb is moving. The objective of this study is to better determine the efficacy of MT. The investigators will therefore compare recovery of arm function in two groups of patient, that perform a regimen of 30 minutes of therapy, 5 times a week, for 4 weeks on top of conventional therapy. One group performs MT and the other one performs a therapy in which the same movements are performed, but without the use of a mirror, with unrestricted view of both limbs. Allocation to each group will be randomized. Arm function will be evaluated by use of a scale before, during and after the 4 week period. The assessor for the primary outcome measure will not know in which group the patient is. There will be a total of 30 patients included over a one year study period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Mirror Therapy

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University Hospital, Geneva trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02949609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing